New research reveals that people who discontinue blockbuster slimming jabs like semaglutide or tirzepatide tend to recover reduced body mass far faster than those who halt traditional diet and exercise plans.
Published data in a leading medical journal shows that while obese people frequently drop substantial amounts of their total mass while undergoing treatment, the weight returns at an average rate of nearly a kilo each month after stopping.
"Individuals buying these treatments must be aware of the potential of fast rebound weight gain when the therapy ends," warns researcher Dr. Susan Jebb.
This pace of regain means a return to starting weight in about one and a half years.
Comparing Approaches
The study, which looked at dozens of trials involving thousands of participants, contrasted the results of these new drugs with conventional dieting.
Researchers emphasize that people who shed pounds through lifestyle changes alone generally see a slower creep back—around 0.1 kg a month—once they finish.
The Reason for the Fast Regain
Experts believe the way of the drugs explains the accelerated weight return.
These medications imitate a body's own chemical called GLP-1, which helps regulate feelings of fullness.
"Artificially providing the hormone concentrations several times higher than normal might result in the body to produce less of its own natural hormone, and could lessen responsiveness to its effects," explained Dr. Adam Collins, a nutrition expert.
"Withdrawal of this hormone supplement means hunger is unsuppressed, making overeating much more probable."
An Ongoing Issue?
Medical guidelines suggest the injections for individuals with weight-linked health risks, alongside prescribed diet and exercise modifications.
Professionals argue that, considering the significant potential of relapse, the therapy is often life-long.
This view is echoed by pharmaceutical companies, who state that the results "emphasize the long-term character of excess weight," similar to managing conditions like hypertension.
User Testimonies
People who have come off the medication explain a intense resurgence of hunger.
"It felt as if a switch that goes on and I was suddenly starving," recalled an individual.
This difficulty is worsened if users have not established permanent lifestyle or habit modifications during therapy.
Widespread Interest
Survey data indicate that a significant number of adults in the UK have tried these injections in the last 12 months, with desire being substantial.
- Adoption is more common among women than men.
- The middle-aged demographic shows the highest level of interest.
- Many obtain the drugs through private healthcare rather than the NHS.
In conclusion, experts stress that while GLP-1 drugs are potent agents for shedding pounds, they are not a magic cure and lasting health benefits likely depends on integrated lifestyle support.
